Takeda's Partner Merges With Crestovo to Form Finch Therapeutics Group Post author:Sam Post published:October 22, 2017 Post category:BioPharma Two privately-held biotechs have merged to tackle recurrent C. difficile infections. Source: BioSpace You Might Also Like Cardinal Health Unloads China Biz to Shanghai Pharma in $1.2B Deal November 14, 2017 2 Tempting Biotech Stocks to Avoid Like Mad March 5, 2017 Hygieia Completes Acquisition Of Global Food Safety Diagnostics Business From DuPont February 28, 2017
Hygieia Completes Acquisition Of Global Food Safety Diagnostics Business From DuPont February 28, 2017
